corona vaccine News

AstraZeneca’s Evusheld slashes risk of symptomatic COVID-19 up to 83%

April 21, 2022 No Comments
Mary Van Beusekom | News Writer | CIDRAP News
Apr 21, 2022

Over 73% of participants were at elevated risk of infection owing to risk factors.

Mary Van Beusekom | News Writer | CIDRAP NewsApr 21, 2022Over 73% of participants were at elevated risk of infection owing to risk factors.Read More

Leave a Reply

Your email address will not be published.